---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000052"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:19:54.864018+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avanos Medical agrees to acquire Diros Technology, RF pain management portfolio strengthened

## Summary
- Deal includes all outstanding shares of Diros Technology; financial terms not disclosed.
- Financed via existing credit facility and available cash; expected to close Q3 2023.
- Diros is a Toronto-based manufacturer of radiofrequency ablation products for chronic pain.
- Avanos expects the acquisition to be immediately accretive to revenue, gross margins, operating margins, and EPS.
- Diros' RF Trident technology complements Avanos' existing COOLIEF Cooled Radiofrequency product line.

## SEC filing metadata
- accession: 0001606498-23-000052
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000052/0001606498-23-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000052/avns-20230619.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000052
- JSON: https://secwatch.observer/filing/0001606498-23-000052.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.